Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Innovex International (INVX) EBT (2016 - 2026)

Innovex International filings provide 17 years of EBT readings, the most recent being $27.0 million for Q4 2025.

  • On a quarterly basis, EBT rose 103.97% to $27.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $128.5 million, a 122.79% increase, with the full-year FY2025 number at $128.5 million, up 122.79% from a year prior.
  • EBT hit $27.0 million in Q4 2025 for Innovex International, down from $58.0 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $80.0 million in Q3 2024 to a low of -$679.3 million in Q4 2024.
  • Median EBT over the past 5 years was $9.3 million (2022), compared with a mean of -$27.0 million.
  • Biggest five-year swings in EBT: skyrocketed 285.31% in 2022 and later plummeted 872.18% in 2024.
  • Innovex International's EBT stood at -$81.9 million in 2021, then skyrocketed by 175.74% to $62.1 million in 2022, then tumbled by 212.59% to -$69.9 million in 2023, then plummeted by 872.18% to -$679.3 million in 2024, then surged by 103.97% to $27.0 million in 2025.
  • The last three reported values for EBT were $27.0 million (Q4 2025), $58.0 million (Q3 2025), and $22.2 million (Q2 2025) per Business Quant data.